\u03a4\u03b1 \u03b2\u03c1\u03b1\u03b2\u03b5\u03af\u03b1 Prix Galien \u03c3\u03c4\u03b9\u03c2 \u0397\u03a0\u0391 \u03b5\u03c0\u03b9\u03b2\u03c1\u03ac\u03b2\u03b5\u03c5\u03c3\u03b1\u03bd \u03c4\u03b7\u03bd \u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03bf\u03bd\u03b9\u03ba\u03ae \u03b1\u03c1\u03b9\u03c3\u03c4\u03b5\u03af\u03b1, \u03c4\u03b7\u03bd \u03ba\u03b1\u03b9\u03bd\u03bf\u03c4\u03bf\u03bc\u03af\u03b1 \u03ba\u03b1\u03b9 \u03c4\u03b7\u03bd\u00a0\u03b1\u03bd\u03b8\u03c1\u03c9\u03c0\u03b9\u03c3\u03c4\u03b9\u03ba\u03ae \u03c0\u03c1\u03bf\u03c3\u03c0\u03ac\u03b8\u03b5\u03b9\u03b1 \u03c3\u03c4\u03b7\u03bd 6\u03b7 \u03c4\u03b5\u03bb\u03b5\u03c4\u03ae \u03b1\u03c0\u03bf\u03bd\u03bf\u03bc\u03ae\u03c2 \u03b2\u03c1\u03ac\u03b2\u03b5\u03c5\u03c3\u03b7\u03c2.<\/p>\n
17 \u039f\u03ba\u03c4. 2012, \u039c\u03bf\u03c5\u03c3\u03b5\u03af\u03bf \u03a6\u03c5\u03c3\u03b9\u03ba\u03ae\u03c2 \u0399\u03c3\u03c4\u03bf\u03c1\u03af\u03b1\u03c2, \u039d. \u03a5\u03cc\u03c1\u03ba\u03b7<\/em><\/p>\n \u039d\u03b9\u03ba\u03b7\u03c4\u03ad\u03c2 \u03c4\u03c9\u03bd \u03b2\u03c1\u03b1\u03b2\u03b5\u03af\u03c9\u03bd Prix Galien \u0397\u03a0\u0391 \u03b3\u03b9\u03b1 \u03c4\u03bf 2012 \u03b1\u03bd\u03b1\u03b4\u03b5\u03af\u03c7\u03b8\u03b7\u03ba\u03b1\u03bd \u03bf\u03b9:<\/p>\n YERVOY<\/strong>\u00ae (ipilimumab) \u03c4\u03b7\u03c2 Bristol-Myers Squibb \u03c3\u03c4\u03b7\u03bd \u03ba\u03b1\u03c4\u03b7\u03b3\u03bf\u03c1\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c4\u03b5\u03c1\u03bf \u03c0\u03c1\u03bf\u03ca\u03cc\u03bd \u03b2\u03b9\u03bf\u03c4\u03b5\u03c7\u03bd\u03bf\u03bb\u03bf\u03b3\u03af\u03b1\u03c2.<\/p>\n VICTRELIS<\/strong>\u00ae (boceprevir) \u03c4\u03b7\u03c2 Merck \u03ba\u03b1\u03b9 INCIVEK<\/strong>\u00ae\u00a0 (telaprevir) \u03c4\u03b7\u03c2 Vertex \u03c3\u03c4\u03b7\u03bd \u03ba\u03b1\u03c4\u03b7\u03b3\u03bf\u03c1\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c4\u03b5\u03c1\u03bf \u03c6\u03b1\u03c1\u03bc\u03b1\u03ba\u03b5\u03c5\u03c4\u03b9\u03ba\u03cc \u03c0\u03c1\u03bf\u03ca\u03cc\u03bd.<\/p>\n SAPIEN Transcatheter Heart Valve<\/strong>\u00a0 \u03c4\u03b7\u03c2 Edwards Lifesciences \u03ba\u03b1\u03b9 Melody<\/strong>\u00ae Transcatheter Pulmonary Valve (TPV)<\/strong> \u03c4\u03b7\u03c2 Medtronic \u03c3\u03c4\u03b7\u03bd \u03ba\u03b1\u03c4\u03b7\u03b3\u03bf\u03c1\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c4\u03b5\u03c1\u03bf \u03b4\u03b9\u03b1\u03b3\u03bd\u03c9\u03c3\u03c4\u03b9\u03ba\u03cc \u03b5\u03c1\u03b3\u03b1\u03bb\u03b5\u03af\u03bf.<\/p>\n \u03a4\u03bf \u03b2\u03c1\u03b1\u03b2\u03b5\u03af\u03bf Pro Bono \u0392\u03c1\u03b1\u03b2\u03b5\u03af\u03bf Humanum \u03b3\u03b9\u03b1 \u03c4\u03bf 2012, \u03b1\u03c0\u03bf\u03bd\u03b5\u03bc\u03ae\u03b8\u03b7\u03ba\u03b5 \u03c3\u03c4\u03bf\u03bd \u03b9\u03b1\u03c4\u03c1\u03cc-\u03b3\u03b5\u03bd\u03b5\u03c4\u03b9\u03c3\u03c4\u03ae Dr. Francis Collins<\/strong>.<\/p>\n